AnaptysBio, Inc. (ANAB)
49.73
+1.83
(+3.82%)
USD |
NASDAQ |
Feb 06, 16:00
49.71
-0.02
(-0.04%)
After-Hours: 20:00
AnaptysBio SG&A Expense (TTM) : 45.14M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 214.26M |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| CorMedix, Inc. | 75.56M |
| Verastem, Inc. | 67.48M |
| Anavex Life Sciences Corp. | 13.82M |